Not a substitute for medical advice. Information on the state of research, not a treatment recommendation. Voices and presenters are AI-generated, not doctors. More (German)
📱 New on Google Play MS Info Channel app – now free on Google Play. Memory Trainer (15 brain games) – still in testing.
Treatments compared

Multiple sclerosis: treatments compared. Conventional, cannabis, psilocybin and natural medicine. What is established?

Besides prescribed therapy, many people with multiple sclerosis ask about cannabis, psilocybin, medicinal mushrooms or medicinal plants. This page puts the approaches side by side and shows how well each is supported. Complementary approaches do not replace disease-modifying therapy.

This text provides general information and is no substitute for medical advice. Diagnosis and treatment belong in the hands of neurologists; never stop prescribed medication on your own. Rules, approvals and guidelines differ from country to country; sources marked (German) refer to Germany.

Why this comparison?

For many approaches we have detailed pages. Here they stand side by side for the first time: what they were studied for, how solid the evidence is, what applies legally in Germany, and where the risks and limits lie.

The table summarises what we know from the sources named. Where we lack a verified source, it says so explicitly. You never change or stop a prescribed therapy on your own, only after talking to your neurologist. Legal information refers to Germany; rules differ from country to country.

The comparison in one table

Treatments for multiple sclerosis compared
ApproachStudied forLevel of evidenceEvidence and sourceLegal status in GermanyMain risks and limitsLearn more
Disease-modifying therapies (conventional)Fewer relapses and new MRI lesions, delaying progression.establishedThese drugs reduce the number of relapses and new MRI lesions and can delay progression; the guideline groups them by disease activity. Source: DGN/AWMF guideline 030-050 (German).Approved medicines, prescribed by a doctor.Each substance has its own side effects and monitoring. For primary progressive MS there are fewer approved options. Never stop on your own.MS treatments at a glance
Relapse treatment and symptom treatmentRelapses with noticeable impairment; spasticity, bladder problems, pain, fatigue, depression.establishedFor a relapse usually high-dose cortisone over a few days, if needed blood-cleansing procedures; complaints are treated with medication, physiotherapy, occupational therapy, speech therapy, neuropsychology and rehabilitation. Source: DGN/AWMF guideline 030-050 (German).Treatment prescribed by a doctor.Which measure fits depends on the symptom and the person and is decided with your doctor.MS treatments at a glance
Cannabis-based medicines (spasticity, pain)Spasticity, neuropathic pain, bladder complaints.establishedfor spasticity only, effect mostly patient-reported; pain and bladder: preliminary; disease course: not establishedMeta-analyses show less patient-reported spasticity, objective measures often show smaller effects; for pain and bladder the data are weaker, and oral THC had no significant effect on progression in the CUPID trial. Sources: meta-analysis (PubMed Central), CAMS-LUTS, CUPID.Only on a doctor's prescription; health insurance does not cover the cost automatically.Dizziness, tiredness, dry mouth; poorer results in thinking tests with regular use; psychotic reactions are possible and dose-dependent; interactions with MS drugs (e.g. cladribine, S1P modulators); fitness to drive must be considered.Cannabis and MS
PsilocybinResearch in depression and anxiety; in MS itself so far only hints of neuroplasticity and anti-inflammatory effects.preclinical onlyfor MS; controlled studies exist for depressionThe phase 3 trial COMP005 met its primary endpoint in treatment-resistant depression; for MS there are only preclinical hints; a phase 2 trial (PsyPal) on psychological distress in life-limiting illness, including MS, is ongoing. Sources: Compass Pathways, ClinicalTrials.gov NCT06782724.Subject to the German Narcotics Act (BtMG) and not approved for medical use in Germany; studies run under controlled conditions.Headache, nausea, temporary anxiety. Not suitable in, among others, psychotic illness, a family history of psychosis, epilepsy, uncontrolled high blood pressure. Long-term safety in MS is unclear.Psilocybin and MS
Medicinal mushrooms (e.g. lion’s mane)Nerve protection and myelin formation in laboratory and animal models.preclinical onlyPreclinical studies show promotion of the maturation of myelin-forming cells; in humans there is a pilot study in healthy volunteers, but no study in MS. For reishi and a few other species there are also only animal studies; for the remaining entries of the database a PubMed search of 18 Nov 2026 found no MS study. Sources: Hericium erinaceus studies (PubMed Central), PMID 36004706, 41957858.Sold as food supplements, not an approved MS medicine.Mushroom allergy; possible effect on blood clotting (caution with blood thinners); possible influence on MS drugs; products are not uniformly standardised; not sufficiently studied in pregnancy and breastfeeding.Medicinal mushrooms
Medicinal plantsThe database lists goals such as stress, fatigue or inflammation for each plant.not establishedpreliminary hints for individual plantsA PubMed search of 18 Nov 2026 across all entries of the database found no plant with a guideline recommendation or several studies with a clearly positive result in MS. Small controlled studies with preliminary hints exist for individual plants (e.g. lavender and saffron for fatigue, ginger for gastrointestinal complaints), and studies without benefit for ginkgo and green tea extract. Sources: PMID 35803088, 32716906, 37891539, 22955125, 33762428; details under Medicinal plants.Sold as food supplements, not an approved MS medicine.Interactions with medication are possible, especially with immunotherapy; clarify with your doctor before use.Medicinal plants
DietInflammation, fatigue, quality of life, body weight and accompanying conditions.preliminaryNo diet reliably affects relapses or MRI activity, except indirectly through body weight; a balanced, plant-based diet is recommended and showed benefits for inflammation markers, fatigue and quality of life. Sources: DGN/AWMF guideline 030-050 (German), WAVES trial.Not a medicine, no prescription needed.There is no MS cure-all diet. Restrictive diets can lead to nutrient deficiencies (B12, iron, calcium), bone loss and underweight. No diet replaces disease-modifying therapy.Podcast on diet (German)
Exercise and physiotherapyFatigue, balance, walking, spasticity, mood and quality of life.establishedas part of symptomatic therapyAccording to the guideline, physiotherapy, occupational therapy and rehabilitation are part of symptomatic MS treatment. Source: DGN/AWMF guideline 030-050 (German).Physiotherapy and occupational therapy on a doctor's prescription; everyday exercise is freely available.Type and intensity must fit the person and are agreed with neurology and therapists; practices such as tai chi need good instruction.Podcast on exercise (German)

The levels of the evidence traffic light are explained below under “How we rate evidence”. On small screens each approach appears as its own block.

The approaches in detail

Disease-modifying therapies

They are the foundation of treatment. The drugs reduce the number of relapses and new MRI lesions and can delay progression. The guideline distinguishes substances for milder and for active courses; the choice depends on disease activity, disease course, other conditions and plans for a family, among other things. New substances such as BTK inhibitors are being studied. More under MS treatments at a glance.

Relapse treatment and symptom treatment

For a relapse with noticeable impairment, high-dose cortisone is usually given; if that is not enough, blood-cleansing procedures may be considered. Spasticity, bladder problems, pain, fatigue or depression can be treated independently of the disease course, with medication and with physiotherapy, occupational therapy, speech therapy, neuropsychology and rehabilitation. Both are part of standard care guided by doctors.

Cannabis-based medicines

Cannabis is best studied for MS-related spasticity: meta-analyses show less patient-reported spasticity, while objective measures often show smaller effects. For pain and bladder complaints the data are weaker. In the CUPID trial, oral THC had no significant effect on the progression of MS. There are side effects and possible interactions with MS drugs, so treatment belongs in medical hands. Details and legal status: Cannabis and MS.

Psilocybin

Psilocybin is mainly researched in depression and anxiety. For MS there are so far only preclinical hints of neuroplasticity and anti-inflammatory effects; an ongoing phase 2 trial (PsyPal) studies psychological distress in life-limiting illness, MS included. In Germany psilocybin is subject to the Narcotics Act and is not approved for medical use. We give no information on obtaining or using it. The state of research is on Psilocybin and MS.

Medicinal mushrooms

For lion’s mane, preclinical studies show effects on nerve protection and the maturation of myelin-forming cells. A study in people with MS is missing; the existing pilot study involved healthy volunteers. For reishi and a few other species there are also only animal studies (PMID 36004706, 41957858); for the remaining mushrooms of the database a PubMed search of 18 Nov 2026 found no MS study. Medicinal mushrooms are food supplements; because of possible interactions, talk to your neurologist first. More under Medicinal mushrooms.

Medicinal plants

The Medicinal plants page lists plant substances with active compounds and stated goals. A PubMed search of 18 Nov 2026 found no guideline recommendation or several studies with a clearly positive result in MS for any of the 61 plants, which is why the traffic light says “not established”. For individual plants there are small controlled studies with preliminary hints (e.g. lavender and saffron for fatigue, ginger for gastrointestinal complaints); for most plants there are only animal studies or no MS studies. That does not mean a plant is ineffective, only that the evidence is missing. The rating per plant is in the column “Evidence in MS” on the Medicinal plants page. Interactions with MS drugs are possible.

Diet

No diet cures MS or reliably prevents relapses. A balanced, mainly plant-based diet is recommended; being overweight is considered unfavourable for the course of the disease. Vitamin D deficiency is common in MS; have your level checked by a doctor and never take high doses without a blood test. Restrictive diets carry the risk of nutrient deficiencies. For a start, see our podcast on diet and supplements (in German).

Exercise and physiotherapy

Physiotherapy, occupational therapy and rehabilitation are an established part of symptomatic therapy. How much and which exercise suits you depends on your symptoms and how you feel that day, and is agreed with neurology and therapists. We discuss the current evidence on sport in our podcast on exercise in MS (in German).

How we rate evidence

Not every study says the same amount. We rank statements by who was studied: first in the cell, then in the animal, then in humans, finally in large controlled trials and guidelines. The further along, the more reliable the statement is for people with MS.

  • Established: effectiveness described in controlled studies in humans or in the guideline for a specific area of use. The rating applies only to that area of use.
  • Preliminary: there are studies in humans, but they are small, inconsistent or not directly about MS. The results still have to be confirmed.
  • Preclinical only: findings come from cell culture or animal models. They show possible mechanisms but do not say whether something helps people with MS.
  • Not established: we have no verified human study source in MS, or the studies showed no effect.

The traffic light says nothing about whether an approach is safe for you personally. You clarify that with your neurologist.

Frequently asked questions

Can I replace my MS therapy with cannabis, psilocybin or medicinal mushrooms?

No. According to the sources named here, none of the complementary approaches replaces a disease-modifying therapy. Always discuss changes to your therapy with your neurologist first.

What does “preclinical only” mean?

The findings come from cell cultures or animal experiments. They do not show that the same effect occurs in people with MS.

Is psilocybin allowed for MS?

In Germany psilocybin is subject to the Narcotics Act and is not approved for medical use. Research takes place in studies under controlled conditions. We give no information on obtaining or using it.

Sources

As of: 2026-11-18. More basics: What is multiple sclerosis (MS)? · MS symptoms: early signs and typical complaints · MS diagnosis: how multiple sclerosis is established · MS treatments at a glance.

MS research in brief

The most important studies explained clearly, every month.

The most important MS studies explained clearly every month: what was studied, how reliable the result is, what is still open. With links to the sources, without promises of a cure.